Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Computer-assisted cognitive stimulation for delirium in older adults

Official title: Clinical, Demographic and Genetic Factors Associated With Response to Computer-assisted Cognitive Stimulation Treatment as Part of Non-pharmacological Care in Patients With Delirium. Feasibility Study.

Run by Institut Investigacio Sanitaria Pere Virgili · NCT07563244 · Data updated 2026-11-12

This will try adding tablet-based cognitive exercises to sleep and mobility support to see if they reduce delirium in people aged 60 and older in subacute care.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment60 (estimated)
SponsorInstitut Investigacio Sanitaria Pere Virgili
Academic / other
Locations1 site (Reus, Tarragona)
StatusRecruiting
StartedFebruary 16, 2026
Main results expectedOctober 16, 2026
Study endsFebruary 16, 2027
Registry record updatedMay 1, 2026
Trial IDNCT07563244 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 60 or older admitted to the subacute care unit with delirium who can provide consent (or have a legal guardian) and have sufficient vision, hearing, and language ability to use a tablet.

Probably not a fit

People under 60, those receiving palliative end-of-life care, or those with severe visual or hearing impairment, aphasia, or serious language barriers are unlikely to be eligible or to benefit from the tablet-based intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients aged 60 and over admitted to a subacute care unit with delirium will receive a package of non-pharmacological therapies focused on regular sleep schedules, increased mobility, and cognitive stimulation. Participants will be divided into two groups: both receive the standard non-drug interventions, and one group also receives twice-daily computer-based cognitive sessions delivered by an occupational therapist on a tablet for one week. Delirium presence and severity will be reassessed after one week, and the study will examine whether individual clinical, laboratory, or demographic factors influence onset, severity, or response to treatment. The trial is conducted at Institut Pere Mata in Reus, Tarragona.

Why it matters

Potential benefit: If successful, adding computer-guided cognitive sessions could shorten delirium episodes and speed recovery in older adults receiving subacute care.

How similar studies have gone: Multicomponent non-pharmacological programs have reduced delirium incidence in prior research, but using twice-daily tablet-based cognitive training to treat active delirium is relatively novel and less well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients aged 60 years or over who are admitted to the subacute care center between 15 February and 15 October 2026 and who sign the informed consent (the patient and their family or legal guardians if the patient's cognitive condition prevents them from giving consent themselves)

Exclusion Criteria:

* Patients who, at the time of admission, meet the criteria for palliative end-of-life care.
* Individuals under 60 years of age, to ensure sample homogeneity and reduce confounding factors.
* Individuals with severe visual or hearing impairment or aphasia, due to the difficulty of carrying out the cognitive intervention.
* Serious communication difficulties due to language.

Where it's running

  • Institut Pere Mata
    Reus, Tarragona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.